A pharmaceutical company with a strategy “let’s try random molecules and do scientific studies whether they cure X” would go out of business.
Funny you should mention this.
Eve is designed to automate early-stage drug design. First, she systematically tests each member from a large set of compounds in the standard brute-force way of conventional mass screening. The compounds are screened against assays (tests) designed to be automatically engineered, and can be generated much faster and more cheaply than the bespoke assays that are currently standard. …Eve’s robotic system is capable of screening over 10,000 compounds per day.
Funny you should mention this.
source